[Skip to Content]
[Skip to Content Landing]
Article
October 25, 1982

Enterococci: Biologic and Epidemiologic Characteristics and In Vitro Susceptibility

Author Affiliations

From the Department of Medicine, The Medical College of Pennsylvania, Philadelphia.

Arch Intern Med. 1982;142(11):2006-2009. doi:10.1001/archinte.1982.00340240028006
Abstract

• Enterococci cause urinary tract infection (usually asymptomatic), 5% to 15% of cases of endocarditis, and rare cases of meningitis. Their role in polymicrobial infection in the abdomen and pelvis is difficult to assess. Ninety percent of enterococci are inhibited by 4 mg/L of penicillin G, by 2 mg/L of ampicillin, and by 6 mg/L of vancomycin. The penicillinase-resistant penicillins, cephalosporins, carbenicillin, and ticarcillin are at least fourfold less active against enterococci than penicillin G, whereas piperacillin has activity equivalent to penicillin G. The addition of an aminoglycoside to penicillin, ampicillin, vancomycin or piperacillin—which are not bactericidal against most strains of enterococci—results in more rapid and complete bactericidal activity (ie, synergistic activity).

(Arch Intern Med 1982;142:2006-2009)

×